Medicare Enrolled

Dr. Jose Llinas Cepeda, M.D.

Endocrinology · Edinburg, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4113 CROSSPOINT BLVD STE 11, Edinburg, TX 78539
9566031555
In practice since 2009 (16 years)
NPI: 1164652533 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Llinas Cepeda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Llinas Cepeda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Llinas Cepeda

Dr. Jose Llinas Cepeda is an endocrinology in Edinburg, TX, with 16 years in practice. Based on federal Medicare data, Dr. Llinas Cepeda performed 1,271 Medicare services across 576 unique beneficiaries.

Between the years covered by Open Payments, Dr. Llinas Cepeda received a total of $102,329 from 40 pharmaceutical and/or device companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Llinas Cepeda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 33% volume in TX$ $102,329 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,271
Medicare services
Top 33% in TX for endocrinology
576
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~79 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)416$86$225
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report192$25$95
Office visit, established patient, complex (40-54 min)187$127$300
Remote patient monitoring device, 30 days122$37$125
Remote patient monitoring management, 20 min/month114$37$85
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes52$30$81
Ultrasound scan of head and neck soft tissue47$70$300
New patient office visit (45-59 min)37$115$350
Drug injection, under skin or into muscle27$10$25
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment23$109$300
Hemoglobin A1c test (diabetes monitoring)22$10$30
New patient office visit, complex (60-74 min)16$137$400
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment16$14$93
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$102,329
Total received (2018-2024)
Avg $14,618/year across 7 years
Top 10% in TX for endocrinology
40
Companies
525
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78,586 (76.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,401 (18.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,342 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17,943
2023
$10,516
2022
$65,367
2021
$1,190
2020
$528
2019
$5,882
2018
$904

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$85,145
Mannkind Corporation
$7,428
Tandem Diabetes Care, Inc.
$1,938
Dexcom, Inc.
$1,260
Ascensia Diabetes Care Us Inc.
$1,079
Abbott Laboratories
$944
AstraZeneca Pharmaceuticals LP
$454
Lilly USA, LLC
$425
Amgen Inc.
$358
Corcept Therapeutics
$326
MannKind Corporation
$326
DEXCOM, INC.
$290
Radius Health, Inc.
$280
Boehringer Ingelheim Pharmaceuticals, Inc.
$276
SANOFI-AVENTIS U.S. LLC
$247
Insulet Corporation
$245
Novartis Pharmaceuticals Corporation
$194
Intuity Medical Inc
$146
MERZ NORTH AMERICA, INC.
$119
Madrigal Pharmaceuticals
$107
Medtronic, Inc.
$82
Horizon Therapeutics plc
$63
Alexion Pharmaceuticals, Inc.
$57
Amarin Pharma Inc.
$54
Esperion Therapeutics, Inc.
$53
Antares Pharma, Inc.
$53
Allergan, Inc.
$49
Senseonics, Incorporated
$44
Amryt Pharma Holdings Ltd
$40
Bayer Healthcare Pharmaceuticals Inc.
$34
Xeris Pharmaceuticals, Inc.
$31
Kyowa Kirin, Inc.
$26
Becton, Dickinson and Company
$25
Chiesi USA, Inc.
$25
Rhythm Pharmaceuticals, Inc.
$24
ABBVIE INC.
$24
CeQur Corporation
$19
Averitas Pharma Inc.
$17
Ascendis Pharma Inc
$13
BETA BIONICS, INC.
$9
Top 3 companies account for 92.4% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BOTOX · BYDUREON · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · IMCIVREE · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 770G · MOUNJARO · MYCAPSSA · NEXLETOL · NOCDURNA · Omnipod · Ozempic · Pogo Automatic Blood Glucose Monitoring System · QUTENZA · RECORLEV · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SYNJARDY · Saxenda · Sogroya · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tresiba · Tymlos · V-GO · Vascepa · Victoza · Wegovy · XYOSTED · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for endocrinology in TX.

Equivalent to $8,051 per 100 Medicare services performed
Looking for a endocrinology in Edinburg?
Compare endocrinologys in the Edinburg area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
10
Per 100K population
1.1
County median income
$52,281
Nearest hospital
SOUTH TEXAS HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Llinas Cepeda is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 10%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Llinas Cepeda experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Llinas Cepeda performed 416 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Llinas Cepeda receive payments from pharmaceutical companies?
Yes. Dr. Llinas Cepeda received a total of $102,329 from 40 companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Llinas Cepeda's costs compare to other endocrinologys in Edinburg?
Dr. Llinas Cepeda's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Llinas Cepeda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →